Tech Company Financing Transactions
Freedom Biosciences Funding Round
Freedom Biosciences closed a funding round on 2/15/2023. Investors included LongeVC.
Transaction Overview
Company Name
Announced On
2/15/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
LongeVC (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94016
USA
San Francisco, CA 94016
USA
Phone
Undisclosed
Website
Email Address
Overview
The company intends to use the funds to advance its current lead ketamine program as well as further multiple additional exploratory programs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dina Burkitbayeva
Chief Scientific Officer
John Krystal
Co-Founder
Hunter Bouchard
Co-Founder
Morgan Springer
Browse more venture capital transactions:
Prev: 2/15/2023: Bento venture capital transaction
Next: 2/15/2023: Nanite venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs